Earnings Per Common Share Attributable to Common Shareholders

9 Months Ended

Sep. 29, 2013

Earnings Per Share [Abstract]

Earnings Per Common Share Attributable to Common Shareholders

Earnings Per Common Share Attributable to Common Shareholders

The following table provides the detailed calculation of Earnings per common share (EPS):

	Three Months Ended				Nine Months Ended
(IN MILLIONS)	September 29, 2013		September 30, 2012		September 29, 2013		September 30, 2012
EPS Numerator––Basic
Income from continuing operations	$	2,588	$	2,989	$	8,779	$	7,543
Less: Net income attributable to noncontrolling interests	6		6		25		22
Income from continuing operations attributable to Pfizer Inc.	2,582		2,983		8,754		7,521
Less: Preferred stock dividends––net of tax	—		1		1		1
Income from continuing operations attributable to Pfizer Inc. common shareholders	2,582		2,982		8,753		7,520
Discontinued operations––net of tax	11		225		10,719		734
Less: Discontinued operations––net of tax, attributable to noncontrolling interests	—		—		39		—
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders	11		225		10,680		734
Net income attributable to Pfizer Inc. common shareholders	$	2,593	$	3,207	$	19,433	$	8,254
EPS Numerator––Diluted
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions	$	2,582	$	2,983	$	8,754	$	7,521
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions	11		225		10,680		734
Net income attributable to Pfizer Inc. common shareholders and assumed conversions	$	2,593	$	3,208	$	19,434	$	8,255
EPS Denominator
Weighted-average number of common shares outstanding––Basic	6,581		7,436		6,938		7,483
Common-share equivalents: stock options, stock issuable under employee compensation plans and convertible preferred stock	75		72		78		67
Weighted-average number of common shares outstanding––Diluted	6,656		7,508		7,016		7,550
Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)	43		180		43		180

^(a)  These common stock equivalents were outstanding for the three and nine months ended September 29, 2013 and September 30, 2012, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.